BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS AND Clinical Outcome
3 results:

  • 1. Expression and epigenetic regulation of cystatin B in lung cancer and colorectal cancer.
    Ma Y; Chen Y; Petersen I
    Pathol Res Pract; 2017 Dec; 213(12):1568-1574. PubMed ID: 29037838
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Serum protein profiling reveals baseline and pharmacodynamic biomarker signatures associated with clinical outcome in mCRC patients treated with chemotherapy ± cediranib.
    Pommier AJ; Shaw R; Spencer SK; Morgan SR; Hoff PM; Robertson JD; Barry ST; Jürgensmeier JM
    Br J Cancer; 2014 Oct; 111(8):1590-604. PubMed ID: 25121956
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Loss of Smad signaling in human colorectal cancer is associated with advanced disease and poor prognosis.
    Xie W; Rimm DL; Lin Y; Shih WJ; Reiss M
    Cancer J; 2003; 9(4):302-12. PubMed ID: 12967141
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.